Tiverton Asset Management’s AbbVie ABBV Stock Holding History

Tiverton Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.07M	Buy	14,188 +8,848	+166%	+$607K	0.04%	285
2019 Q2	$388K	Sell	5,340 -4,056	-43%	-$319K	0.01%	431
2019 Q1	$757K	Buy	+9,396	New	+$769K	0.03%	278
2018 Q2	–	Sell	-16,310	Closed	-$1.54M	–	405
2018 Q1	$1.54M	Sell	16,310 -6,613	-29%	-$726K	0.11%	129
2017 Q4	$2.22M	Buy	+22,923	New	+$2.16M	0.14%	133
2015 Q3	–	Sell	-300,000	Closed	-$20.2M	–	150
2015 Q2	$20.2M	Sell	300,000 -130,000	-30%	-$8.49M	0.4%	73
2015 Q1	$25.2M	Hold	430,000	–	–	0.51%	66
2014 Q4	$28.1M	Hold	430,000	–	–	0.59%	62
2014 Q3	$24.8M	Hold	430,000	–	–	0.57%	65
2014 Q2	$24.3M	Hold	430,000	–	–	0.54%	65
2014 Q1	$22.1M	Hold	430,000	–	–	0.48%	73
2013 Q4	$22.7M	Hold	430,000	–	–	0.5%	72
2013 Q3	$19.2M	Hold	430,000	–	–	0.46%	74
2013 Q2	$17.8M	Buy	+430,000	New	+$18.8M	0.46%	70

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Tiverton Asset Management's ABBV Position: Q3 2019 in Review

Tiverton Asset Management increased its AbbVie (ABBV) stake by 166% in Q3 2019, buying an estimated $607K and bringing the position to 14,188 shares worth $1.07M. The position accounts for 0.04% of the portfolio, ranked #285.

Tiverton Asset Management first reported a position in ABBV in Q2 2013 and has held it in 14 quarters since. The position peaked at $28.1M in Q4 2014. 2,002 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

Tiverton Asset Management held 14,188 shares of AbbVie worth $1.07M as of Q3 2019.
Tiverton Asset Management bought 8,848 AbbVie shares in Q3 2019, an estimated $607K.
AbbVie made up 0.04% of Tiverton Asset Management's portfolio in Q3 2019, its #285 holding.
Tiverton Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 14 quarters since.
Tiverton Asset Management's AbbVie position peaked at $28.1M in Q4 2014.
2,002 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.